The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
ethyl 2-(3-(1,3-dioxoisoindolin-2-ylamino)-2-formyl-4-oxoazetidin-1-yl)-3-phenylpropanoate ID: ALA2282137
PubChem CID: 76316202
Max Phase: Preclinical
Molecular Formula: C23H21N3O6
Molecular Weight: 435.44
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCOC(=O)C(Cc1ccccc1)N1C(=O)C(NN2C(=O)c3ccccc3C2=O)C1C=O
Standard InChI: InChI=1S/C23H21N3O6/c1-2-32-23(31)17(12-14-8-4-3-5-9-14)25-18(13-27)19(22(25)30)24-26-20(28)15-10-6-7-11-16(15)21(26)29/h3-11,13,17-19,24H,2,12H2,1H3
Standard InChI Key: GXWYGSHMALEUBV-UHFFFAOYSA-N
Molfile:
RDKit 2D
32 35 0 0 0 0 0 0 0 0999 V2000
13.7844 -0.9529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0316 -0.1676 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.0005 -1.2203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0125 -2.0428 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8036 -2.2885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0672 -3.0703 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.3027 -2.4657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5830 -2.0624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5731 -1.2363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2808 -0.8170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2774 -1.6163 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.1023 -1.6058 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.6837 -2.1909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6831 -3.0166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5080 -3.0166 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.5080 -2.1916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0916 -1.6085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8885 -1.8224 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.0995 -3.5997 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.0914 -3.5999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8779 -4.3969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8883 -3.3864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4717 -3.9698 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.1018 -2.5896 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.2685 -3.7563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8519 -4.3396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4612 -4.9802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2460 -5.7766 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8286 -6.3596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6264 -6.1463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8384 -5.3446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2544 -4.7650 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
1 3 1 0
3 4 1 0
4 5 1 0
5 6 2 0
4 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
3 10 2 0
1 11 1 0
5 11 1 0
11 12 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 13 1 0
13 12 1 0
16 17 1 0
17 18 2 0
14 19 2 0
15 20 1 0
20 21 1 0
20 22 1 0
22 23 1 0
22 24 2 0
23 25 1 0
25 26 1 0
21 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 27 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 435.44Molecular Weight (Monoisotopic): 435.1430AlogP: 0.74#Rotatable Bonds: 8Polar Surface Area: 113.09Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.58CX Basic pKa: 0.51CX LogP: 1.52CX LogD: 1.52Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.28Np Likeness Score: -0.33
References 1. Jarrahpour A, Sheikh J, El-Mounsi I, Mouhoub R, Hadda TB. (2013) Computational evaluation and experimental verification of antibacterial activity of some -lactams: advantages and limitations, 22 (3): [10.1007/s00044-012-0126-7 ]